Can Existing Drug Approval Pathways Adequately Address Novel Peptide-Drug Interactions?
Existing drug approval pathways require significant adaptation to fully address the unique complexities of novel peptide-drug interactions and ensure patient safety.
HRTioJuly 21, 2025